AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04638062 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1.Post Isometric Relaxation
Description: For Upper Trapezius In supine position Neck flexion, contra-lateral full side bending followed by slight ipsilateral rotation will be provided towards the side being treated. while asking the patient to shrug the stabilized shoulder and contraction will be maintained for 7- 10s. Repeating it 3-5 times.~For Levator Scapulae Step One In supine position while lifting the patients neck in full flexion, lateral flexion and rotation with 7-10s isometric contraction away from side to be treated will be provided.~Step Two The patient will be instructed to take head backwards to the table while at the same time asking the patient to slightly shrug the shoulder and resistance will be provided. Repeating it 3-5 times.~2.Neck isometric strengthening exercises Intensity 5 reps Frequency at 1st week one set and second week will progress to 2 sets~3.Cryotherapy will be placed on cervical region for 10 min after the treatment.
Study NCT04638062 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1.Myofascial Release therapy
Description: For Upper Trapezius In sitting position Myofascial Release of Trapezius will be performed unilaterally with soft fist or elbow sinking and then taking up the line of tension from mid belly of Trapezius, to the acromion process, while the patient drops the head forward and will slowly rotate the head from side to side. While providing the resistance to contralateral side of rotation. Repeating for 2-3 times.~For Levator Scapulae In sitting position applying same unilateral muscle release as Trapezius, but the line of tension will be to the inferior border of Scapulae slightly laterally and will ask the patient to drop the head forward to increase resistance on Levator muscle. Repeating it 2-3 times~2.Neck isometric strengthening exercises Intensity 5 reps Frequency at 1st week one set and second week will progress to 2 sets~3.Cryotherapy will be placed on cervical region for 10 min after the treatment.
Study NCT03451071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gardasil9
Description: Gardasil 9
Study NCT03727165 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Continuous enteral nutrition infusion
Description: Enteral nutrition administration in continuous infusion during 24 hours per day
Study NCT03727165 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cyclic enteral nutrition infusion
Description: Enteral nutrition administration in continuous infusion during 16 hours per day
Study NCT02667899 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: deep brain stimulation
Description: Deep brain stimulation means stimulate the brain with DBS.
Study NCT02667899 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial magnetic stimulation
Description: Transcranial magnetic stimulation means stimulate the brain with magnetic stimulation.
Study NCT02667899 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Routine treatment
Description: Means without above additional treatment.
Study NCT01741077 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: folic acid
Description: subjects take multivitamin supplement containing folic acid. Women were enrolled based on whether or not they were taking supplements.
Study NCT03764605 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Patieny will be treated by using Metformin from 500 mg a day to 500 mg thrice a day.
Study NCT03764605 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tolvaptan
Description: Patients will be treated with tolvaptan from 45 mg + 15 mg a day to 90 mg + 30 mg a day
Study NCT03689517 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: participants took placebos (pills made by starch) that were told to be an effective analgesic.
Study NCT03689517 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: orthodontic elastic separators
Description: Orthodontic pain was introduced by placement of orthodontic elastic separators to the mesial and distal sides of the right mandibular first molar.
Study NCT03689517 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: orthodontic elastic separators
Description: Orthodontic pain was introduced by placement of orthodontic elastic separators to the mesial and distal sides of the right mandibular first molar.
Study NCT02738502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: darunavir monotherapy
Description: darunavir 600 mg + ritonavir 100 mg 2 times 24 (DRV/r) monotherapy started after checking the tolerance of DRV/r600 mg/100 mg twice daily to replace whatever prior ARVs were used, while maintaining the NRTI backbone for 2 weeks.
Study NCT03798236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PBF-1650 oral capsules
Description: Adenosine A3 receptor (AA3R) antagonist
Study NCT03798236 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: solid microcrystalline cellulose
Study NCT01855269 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Lactobacillus reuteri
Description: Lactobacillus reuteri (BioGaia, Stockholm, Sweden):at a dose of 100 million colony forming unit in 5 drops, 30 minutes after feeding, once per day for 3 weeks
Study NCT01855269 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Herbal drop
Description: Herbal drop containing sodium bicarbonate, Pimpinella anisum oil,foeniculum vulgare oil, Mentha piperita (Babs, Berko, Istanbul, Turkey):5 drops 30 minutes after feeding, once per day for 3 weeks
Study NCT01855269 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo sterile water
Study NCT02737722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisphosphocin Nu-3
Study NCT02737722 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04152590 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Uincare
Description: Interactive digital healthcare system
Study NCT00379106 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arm exercises.
Description: Basic active exercise program at home.
Study NCT00379106 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arm Exercises
Description: Instruction in the same active exercise program along with additional exercises using exercise equipment and stretching exercises
Study NCT02751229 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Honest Open Proud (HOP)
Description: five lessons in three modules, two for each two-hour session~1. Considering pros and cons of disclosing:~   * hurtful and helpful attitudes about mental illness~  * identify beliefs participants hold about themselves~  * explore five-step process to challenge their personally hurtful beliefs~  * weigh pros and cons of coming out in order to facilitate a decision on whether to disclose~2. Different ways to disclose:~   * different levels of (non-) disclosure and how to weigh the cons and pros~  * disclosure via social media versus disclosing face to face~  * how to find people that are better to disclose to than others and how to 'test them out'~  * participants will discuss how others might respond to their disclosure and how that will affect them~3. Telling your story:~   * how to tell one's story in a personally meaningful way, how to identify peers who might help with the coming out process, to review how telling one's story felt
Study NCT03675217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PE
Description: Physical exercise program for familiy caregivers. 36 session physical exercise (3 sessions/week) performed by physioterapist. It incluided exercices to improve coordination, aerobic capacity, control motor and strenght
Study NCT03675217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Usual Programe in primary care for family caregivers. 4 session (2 session/week). It incluides: ergonomy, postural hygiene, mobilitation of patients and self-care.
Study NCT03675217 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual Programe in primary care for family caregivers. 4 session (2 session/week). It incluides: ergonomy, postural hygiene, mobilitation of patients and self-care.
Study NCT03365180 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Starter Kit Algorithm
Description: Long acting insulin titration to target
Study NCT00318695 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: Bifidobacterium longum \[BL999\] and Lactobacillus rhamnosus \[LPR\]
Study NCT00318695 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Commercially available cow's milk based infant formula without probiotic supplementation
Study NCT01940822 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Energy Drink
Study NCT01940822 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo Drink
Study NCT03713099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microwave ablation
Description: Microwave ablations will be performed under general anesthesia via a transbronchial approach by an interventional pulmonologist or thoracic surgeon. Prior to the ablation, the treating physician will perform an endobronchial ultrasound (EBUS) to confirm disease staging.
Study NCT02327234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ibuprofen
Description: 2x 200mg ibuprofen, single dose, blinded in 00 capsules
Study NCT02327234 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: lactose filled 00 capsules to match appearance of ibuprofen intervention
Study NCT06233708 — intervention group
Intervention type: DRUG
Intervention: Non-Selective Beta-Adrenoreceptor Agonists for Systemic Use
Description: Non-selective blocker including Propranolol, Carvedilol PO was prescribed
Study NCT03099525 — intervention group
Intervention type: OTHER
Intervention: ILD
Description: This is an observational study without any intervention.
Study NCT01932385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Study NCT01932385 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Supportive Care
Study NCT01932385 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Supportive Care
Study NCT00133796 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herceptin
Description: IV
Study NCT01380366 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Somatropin
Description: Patients are given somatropin (growth hormone) for their short bowel syndrome for 28 days at a dose of 0.1 mg/kg subcutaneously daily to a maximum of 8 mg daily.
Study NCT01380366 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Seven Day Food Diary
Description: Subjects are asked to fill out a seven day food diary the week prior to their inpatient appointment, prior to receiving rHGH treatment for their short bowel syndrome. Subjects will be asked to repeat the use of a food diary after completing the administration of the growth hormone.
Study NCT01380366 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood Tests (standard of care)
Description: Blood tests are taken (standard of care) to evaluate the potential hepato-protective effects of improving intestinal barrier function on those receiving human growth hormone for short bowel syndrome. Per clinical protocol to test liver function i.e. Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline phosphatase (ALP), Gamma-glutamyl transpeptidase (GGT), Total Bilirubin). A complete blood count (CBC) with platelets (PLTS) and white-count differential (WBC with diff) is performed to check for anemia and infection. These tests will be taken at baseline (before fasting) and repeated again on the 28th day (last dose) of the growth hormone. Blood is also taken at clinical visit over the next two years (approximately every two months).
Study NCT01380366 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Fasting
Description: Eight hour overnight fast prior to being given sucralose, mannitol, lactulose, and sucrose. This is done at baseline (day one) and repeated again after the last dose of growth hormone and prior to sugar permeability urine tests.
Study NCT01380366 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sugar Permeability Test
Description: Subject will be given 4 capsules of sucralose (250mg per capsule), 2.0 grams of mannitol, 7.5 grams of lactulose, and 40 grams of sucrose in 150 mL of water. This will be given on the second day of the study after an 8-hour overnight fast and repeated within 72 hours of the last dose of growth hormone.
Study NCT01380366 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Urine Collection
Description: Urine will be collected for the following five hours after subject has been given combination of sucralose, mannitol, lactulose, and sucrose to complete the intestinal sugar permeability test looking at urine ratio of lactulose to mannitol (L/M ratio). Tests include urinalysis (UA) and a blood urea nitrogen (BUN)/creatinine (Cr).
Study NCT01019993 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional OLV followed with IL-HFPPV
Description: The patients' lungs were mechanically ventilated with intermittent positive pressure ventilation using fraction of inspired oxygen (FiO2) of 0.5 in air, tidal volume (VT) of 8 mL/kg, inspiratory to expiratory \[I: E\] ratio of 1:2.5, zero positive end-expiratory pressure (PEEP), respiratory rate (R.R) was adjusted to achieve an arterial carbon dioxide tension (PaCO2) 35-45 mm Hg and peak inspiratory pressures were limited to 35 cm H2O. After pleurotomy, OLV was initiated with the same ventilatory settings for the dependent lung. After 30 min, the non-dependent collapsed lung was ventilated using HFPPV mode (IL-HFPPV) with another identical ventilator, with an internal circuit of low compliance, using FiO2 of 0.5 in air, VT 3 mL/kg, I: E ratio \<0.3 and R.R 60 breaths/min.
Study NCT03444207 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Endurance training
Description: The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity.
Study NCT03444207 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Endurance-strength training
Description: Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate.
Study NCT00774475 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: comparison of different dosage of clopidogrel
Description: clopidogrel 75 mg/day versus clopidogrel 150 mg/day
Study NCT00774475 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doubled therapy
Description: clopidogrel 150 mg/day
Study NCT03641027 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Increased physical activity
Description: Preoperatively~Individual coaching by a physical therapist to:~* increase physical activity 30 minutes/day (At least 150 min/week)~* decrease time spent sitting/lying~Telephone follow up one week after the intervention starts~At the hospital~-Frequent mobilization~After discharge~A telephone follow up one week postoperatively with coaching by a physical therapist to:~* increase physical activity 30 minutes/day (At least 150 min/week) until 8 weeks postoperatively~* decrease time spent sitting/lying~The intervention includes a prescribed FaR (Fysisk aktivitet på recept) with frequency, duration and intensity of the activity corresponding 12-15 on the BORG-RPE scale.
Study NCT03641027 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard care
Study NCT04264741 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: repetitive transcranial magnetic stimulation (rTMS)
Description: The iTBS group received 900 pulses per day: 3-pulse 50-Hz bursts given every 200 ms (at 5 Hz), 2 s on and 8 s off for 5 min, at 100% resting motor threshold (rMT), over the left DLPFC (F3, EEG system) (4 weeks, 20 daily sessions). A figure-8-shaped Cool-B70 stimulation coil from MagPro X100 device (MagVenture, Farum, Denmark) was used for accurately targeted stimulation. Motor threshold was determined over the left motor cortex, by finding the lowest intensity that produced a motor response in the right abductor pollicis brevis muscles (APB), which produced five motor-evoked potentials responses of at least 50 mV in 10 trials.
Study NCT04264741 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham repetitive transcranial magnetic stimulation (rTMS)
Description: The iTBS group received 900 pulses per day: 3-pulse 50-Hz bursts given every 200 ms (at 5 Hz), 2 s on and 8 s off for 5 min, at 100% resting motor threshold (rMT), over the left DLPFC (F3, EEG system) (4 weeks, 20 daily sessions). A figure-8-shaped sham Cool-B70 stimulation coil from MagPro X100 device (MagVenture, Farum, Denmark) was used for accurately targeted stimulation. Motor threshold was determined over the left motor cortex, by finding the lowest intensity that produced a motor response in the right abductor pollicis brevis muscles (APB), which produced five motor-evoked potentials responses of at least 50 mV in 10 trials.
Study NCT02679976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: etafilcon A
Description: Marketed Multifocal Contact Lens
Study NCT03603613 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: YRI
Description: The YRI is designed to assist youth facing complex problems using evidence-based treatments that have been tested and shown to work well in other settings and cultures. The YRI has three specific goals: 1) develop emotion regulation skills for healthy coping; 2) develop problem-solving skills to assist with achieving goals, and; 3) improve interpersonal skills to enable healthy relationships and effective communication. It integrates six CBT-based, empirically-supported practice elements shown to have transdiagnostic efficacy across disorders ranging from major depressive disorder to PTSD and conduct disorders. The YRI's six evidence-based components are delivered in three phases common in trauma-informed interventions: stabilization, integration, and connection.
Study NCT03603613 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EPP
Description: The youth capacity development component of GIZ's EPP includes the following core components: financial literacy, entrepreneurship, and vocational training delivered through six modules (agro-processing, solar photovoltaic installation and maintenance, governance and conflict resolution, psychosocial competencies, entrepreneurship, employability). Youth will be trained at training sites and have access to a youth center in the area. These centers will have agricultural equipment and machinery available for youth to use. Our YRI curriculum will be used for the psychosocial competency training module.
Study NCT04009837 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hip-focused rehabilitation intervention
Description: The hip-focused intervention includes a blend of hip-focused rehabilitative techniques and some basic lumbar spine-directed techniques. The hip-focused arm includes tailored manual therapy, progressive strengthening exercises, and flexibility exercises for the hip, as well as spinal flexibility and trunk muscle training exercises. The intervention will be delivered by licensed physical therapists in one-hour sessions, twice per week, for 8 weeks.
Study NCT04009837 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Spine-focused rehabilitation intervention
Description: The spine-focused rehabilitation intervention is a direct and comprehensive lumbar spine rehabilitative program, but it does not include hip treatment. The spine-focused arm includes spinal manual therapy, spinal flexibility exercises, and trunk muscle training exercises. The intervention will be delivered by licensed physical therapists in one-hour sessions, twice per week, for 8 weeks.
Study NCT01244464 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IMOVAX Polio™-Inactivated types 1, 2, and 3 poliovirus D vaccine
Description: 0.5 mL, at 2, 3, and 4 months; Intramuscular
Study NCT04270188 — intervention group
Intervention type: OTHER
Intervention: evolution of patient symptoms
Description: evolution of symptoms on the PGI-I scale (score 1, 2, or 3) 2 months after surgery
Study NCT04443192 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ZF874
Description: ZF874 is a novel chemical chaperone that is specifically designed to rescue the folding of the Z variant of alpha-1-antitrypsin (A1AT). It is being developed for the treatment of alpha-1-antitrypsin deficiency (AATD) caused by the Z-mutation.
Study NCT04443192 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to ZF874
Study NCT01553851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1120212
Description: Trametinib (GSK1120212) is a selective MEK1 and MEK2 inhibitor with selective activity towards BRAF and RAS mutant cancer cell lines and hematopoietic cancer cells from AML and CML origins.
Study NCT00205166 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac SPECT imaging Rest and Stress
Description: adenosine perfusion scintigraphy
Study NCT00205166 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Caffeine
Description: Caffeine 400 mg po